CenterBook Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,637
Closed -$1.06M 755
2026
Q1
$1.06M Sell
3,637
-8,686
-70% -$2.85M 0.06% 345
2025
Q4
$4.32M Buy
12,323
+245
+2% +$82.8K 0.21% 127
2025
Q3
$3.9M Buy
12,078
+2,033
+20% +$632K 0.19% 144
2025
Q2
$3.91M Buy
10,045
+7,223
+256% +$2.91M 0.22% 127
2025
Q1
$1.23M Sell
2,822
-33,890
-92% -$13.6M 0.08% 284
2024
Q4
$13.5M Buy
36,712
+30,954
+538% +$13M 0.81% 23
2024
Q3
$2.99M Sell
5,758
-2,071
-26% -$1.11M 0.18% 142
2024
Q2
$4.24M Buy
+7,829
New +$4.14M 0.26% 145
2023
Q1
Sell
-3,732
Closed -$1.91M 407
2022
Q4
$1.91M Buy
3,732
+1,000
+37% +$508K 0.32% 106
2022
Q3
$1.24M Buy
2,732
+1,348
+97% +$645K 0.24% 145
2022
Q2
$668K Buy
1,384
+261
+23% +$129K 0.14% 244
2022
Q1
$552K Buy
1,123
+685
+156% +$313K 0.2% 186
2021
Q4
$203K Buy
+438
New +$184K 0.12% 266

Other funds holding ELV

CenterBook Partners's ELV Position: Q2 2026 in Review

CenterBook Partners sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 3,637 shares — an estimated $1.06M sold.

CenterBook Partners first reported a position in ELV in Q4 2021 and held it in 13 quarters. The position peaked at $13.5M in Q4 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • CenterBook Partners reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • CenterBook Partners sold 3,637 Elevance Health shares in Q2 2026, an estimated $1.06M.
  • CenterBook Partners first reported a position in Elevance Health in Q4 2021 and held it in 13 quarters.
  • CenterBook Partners's Elevance Health position peaked at $13.5M in Q4 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.